Maternal immunization with Haemophilus influenzae type b polysaccharide-tetanus protein conjugate vaccine in The Gambia

JAMA

Volumn 275, Issue 15, 1996, Pages 1182-1188

  Mulholland, Kim ^a,g   Suara, Rahaman O ^a   Siber, George ^b   Roberton, Don ^c   Jaffar, Shabbar ^a   N'Jie, Jainaba ^a   Baden, Lindsey ^a   Thompson, Claudette ^b   Anwaruddin, Raana ^b   Dinan, Leonie ^c   Glezen, W Paul ^d   Francis, Nicholas ^e   Fritzell, Bernard ^f   Greenwood, Brian M ^a  

^a MEDICAL RESEARCH COUNCIL LABORATORIES   (Gambia)

^b DANA FARBER CANCER INSTITUTE   (United States)

^c UNIVERSITY OF ADELAIDE   (Australia)

^d BAYLOR COLLEGE OF MEDICINE   (United States)

^e IMPERIAL COLLEGE SCHOOL OF MEDICINE   (United Kingdom)

^f Pasteur Merieux Serums et Vaccins   (France)

^g WORLD HEALTH ORGANIZATION   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

HAEMOPHILUS INFLUENZAE TYPE B VACCINE; MENINGOCOCCUS VACCINE; TETANUS TOXOID;

ADULT; ANTIBODY TITER; ARTICLE; DISEASE CONTROL; FEMALE; GAMBIA; HUMAN; HUMAN EXPERIMENT; IMMUNE RESPONSE; IMMUNIZATION; PLACENTAL TRANSFER; PRIORITY JOURNAL; STILLBIRTH; VACCINATION;

EID: 0029863489     PISSN: 00987484     EISSN: None     Source Type: Journal    
DOI: 10.1001/jama.275.15.1182     Document Type: Article

References (36)

1. Shapiro E. Infections caused by Haemophilus influenzae type b: the beginning of the end? JAMA. 1993;269:264-266.
2. Adams WG, Deaver KA, Cochi SL, et al. Decline of childhood Haemophilus influenzae type b (Hib) disease in the Hib vaccine era. JAMA. 1993;269: 221-226.
3. Makela PH, Takala AK, Peltola H, Eskola J. Epidemiology of invasive Haemophilus influenzae type b disease. J Infect Dis. 1992;165(suppl 1):S2-S6.
4. Bijlmer HA. Epidemiology of Haemophilus influenzae invasive disease in developing countries and intervention strategies. In: Ellis RW, Granoff DM, eds. Development and Uses of Haemophilus b Conjugate Vaccines. New York, NY: Marcel Dekker; 1994:247-264.
5. Funkhouser A, Steinhoff MC, Ward J. Haemophilus influenzae disease and immunization in developing countries. Rev Infect Dis. 1991;13(suppl 6)S542-S554.
6. Bijlmer HA, van Alphen L, Greenwood BM, et al. The epidemiology of Haemophilus influenzae meningitis in children under five years of age in The Gambia, West Africa. J Infect Dis. 1990;161:1210-1215.
7. Tall FR, Elola A, Prazuk T, et al. Méningites à Haemophilus influenzae à Bobo-Dioulasso (Burkina Faso). Méd Mal Infect. 1992;22:1173-1177.
8. Abdul-Rauf A, Schreiber JR. Neonatal Haemophilus influenzae type b sepsis. Pediatr Infect Dis J. 1990;9:918-921.
9. Burckhardt AE. Zur intrauterinen Vaccination. Dtsch Arch Klin Med Leipzig. 1879;24:506-509.
10. Cohen P, Scadron S. The placental transmission of protective antibodies against whooping cough by inoculation of the pregnant mother. JAMA. 1943; 121:656-662.
11. Vincent-Ballereau F, Fortier B, Armand J, Lafaix Ch. Vaccination pneumococcique chez la femme enceinte en Afrique et immunité passive de l'enfant. Pathol Biol (Paris). 1985;33:764-767.
12. Baker CJ, Rench MA, Edwards MS, et al. Immunization of pregnant women with a polysaccharide vaccine of group B streptococcus. N Engl J Med. 1988;319:1180-1185.
13. Black RE, Huber DH, Curlin GT. Reduction of neonatal tetanus by mass immunization of non-pregnant women: duration of protection provided by one or two doses of aluminium-adsorbed tetanus toxoid. Bull World Health Organ. 1980;58:927-930.
14. Englund JA, Mbawuike IN, Hammill H, et al. Maternal immunization with influenza or tetanus toxoid vaccine for passive antibody protection in young infants. J Infect Dis. 1993;168:647-656.
15. Siber GR, Santosham M, Reid GE, et al. Paired antibody response to Haemophilus influenzae type b polysaccharide and low IgG2 and IgG4 concentrations in Apache children. N Engl J Med 1990; 323:1887-1392.
16. Insel R, Anderson P. Haemophilus influenzae type b: assays for the capsular polysaccharide and for anti-polysaccharide antibodies. In: Rose NR, Friedman H, Fahey JL, eds. Manual of Clinical Laboratory Immunology. 3rd ed. Washington, DC: American Society for Microbiology; 1985:379-384.
17. Zollinger WD, Boslego JW. A general approach to standardization of the solid-phase radioimmunoassay for quantitation of class-specific antibodies. J Immunol Methods. 1981;46:129-140.
18. Bulmer JN, Rasheed FN, Francis N, Morrison L, Greenwood BM. Placental malaria, I: pathological classification. Histopathology. 1993;22:11-218.
19. Käyhty H, Peltola H, Karanko V, Makela PH. The protective level of serum antibodies to the capsular polysaccharide of Haemophilus influenzae type b. J Infect Dis. 1983;147:1100.
20. Montgomery DC, Peck EA. Introduction to Linear Regression Analysis. New York, NY: John Wiley & Sons Inc; 1982.
21. Draper N, Smith H. Applied Regression Analysis. 2nd ed. New York, NY: John Wiley & Sons Inc; 1981.
22. Mulholland EK, Byass P, Campbell H, et al. The immunogenicity and safety of Haemophilus influenzae type b-tetanus toxoid conjugate vaccine in Gambian infants. Ann Trop Paediatr. 1994; 14:183-188.
23. Amstey MS, Insel R, Munoz J, et al. Fetal-neonatal passive immunization against Hemophilus influenzae, type b. Am J Obstet Gynecol. 1985; 153:607-611.
24. Glezen WP, Englund JA, Siber GR, et al. Maternal immunization with the capsular polysaccharide vaccine for Haemophilus influenzae type b. J Infect Dis. 1992;165(suppl 1):S134-S136.
25. Englund JA, Glezen WP, Turner C, Harvey J, Thompson C, Siber GR. Transplacental antibody transfer following maternal immunization with polysaccharide and conjugate Haemophilus influenzae type b vaccines. J Infect Dis. 1995;171:99-105.
26. Zajac BA, West DJ, McAleer WJ, Scolnick EM. Overview of clinical studies with hepatitis B vaccine made by recombinant DNA. J Infect. 1986;13 (suppl A):39-45.
27. Herzenberg LA, Tokuhisa T, Herzenberg LA. Carrier-priming leads to hapten-specific suppression. Nature. 1980;285:664-667.
28. Di John D, Wasserman SS, Torres JR, et al. Effect of priming with carrier on response to conjugate vaccine. Lancet. 1989;2:1415-1418.
29. Gill TJ, Repetti CF, Metlay LA, et al. Transplacental immunization of the human fetus by immunization of the mother. J Clin Invest. 1983;72: 987-996.
30. Claesson BA, Schneerson R, Robbins JB, et al. Protective concentrations of serum antibodies stimulated in infants by two injections of Haemophilus influenzae type b capsular polysaccharide-tetanus toxoid conjugate. J Pediatr. 1989;114:97-100.
31. Mulholland EK, Hoestermann A, Suara RO, et al. Haemophilus influenzae type b meningitis after three doses of vaccine. Lancet. 1994;343:794.
32. Santosham M, Wolff M, Reid R, et al. The efficacy in Navajo infants of a conjugate vaccine consisting of Haemophilus influenzae type b polysaccharide and Neisseria meningitidis outer-membrane protein complex. N Engl J Med. 1991;324:1767-1772.
33. Kurikka S, Käyhty H, Peltola H, et al. Neonatal immunization: response to Haemophilus influenzae type b-tetanus toxoid conjugate vaccine. Pediatrics. 1995;95:815-822.
34. Takala AK, Eskola J, Leinonen M, et al. Reduction of oropharyngeal carriage of Haemophilus influenzae type b (Hib) in children immunized with an Hib conjugate vaccine. J Infect Dis. 1991;164: 982-986.
35. Murphy TV, Pastor P, Medley F, Osterholm MT, Granoff DM. Decreased Haemophilus colonization in children vaccinated with Haemophilus influenzae type b conjugate vaccine. J Pediatr. 1993;122:517-523.
36. Takala AK, Santosham M, Almeido-Hill J, et al. Vaccination with Haemophilus influenzae type b meningococcal protein conjugate vaccine reduces oropharyngeal carriage of Haemophilus influenzae type b among American Indian children. Pediatr Infect Dis J. 1993;12:593-599.